StratDeck

Two stocks in Healthcare

Gerresheimer vs Zealand Pharma A/S: profit, growth, debt and price compared

Gerresheimer and Zealand Pharma A/S are each stronger on 3 of 6 figures: Gerresheimer on sales growth, price for its expected profit and price trend; Zealand Pharma A/S on profit margin, debt and analysts' view.

Figures as of 18 November 2026Yahoo Finance
Explore Gerresheimer's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Gerresheimer and Zealand Pharma A/S side by side
GerresheimerGXI.DEZealand Pharma A/SZEAL.CO
Net margin−17.5%Stronger: 67.2%
Revenue growth, past yearStronger: −0.80%−92.00%
Debt to equity236.7%Stronger: 2.8%
Forward P/EStronger: 13.5×30.7×
Dividend yield——
AnalystsHold · 12Stronger: Buy · 12
From its 200-day averageStronger: +13.7%−28.0%

Share price over the past year

  • Gerresheimer+40.9%
  • Zealand Pharma A/S−59.4%

20 Nov 202518 Nov 2026

Gerresheimer or Zealand Pharma A/S: which is stronger?

  • ZEAL.CO

    Which is more profitable?

    Zealand Pharma A/S keeps more of each sale as profit: 67.2% against −17.5%.

  • GXI.DE

    Which is growing its sales faster?

    Gerresheimer is growing its sales faster: −0.80% over the past year, against −92.00%.

  • ZEAL.CO

    Which has borrowed less?

    Zealand Pharma A/S has borrowed less: its debt is 2.8% of what its shareholders own, against 236.7% for Gerresheimer.

  • GXI.DE

    Which costs less for the profit it is expected to make?

    Gerresheimer costs less for the profit it is expected to make: 13.5× its forward earnings, against 30.7×.

  • Which pays more in dividends?

    Neither pays a dividend.

  • ZEAL.CO

    Which do analysts rate higher?

    Analysts are warmer on Zealand Pharma A/S: Buy, against Hold for Gerresheimer.

  • GXI.DE

    Which is in the stronger price trend?

    Gerresheimer's price is in the stronger trend: 13.7% above its 200-day average, against 28.0% below.

What each company does

GXI.DEGerresheimer

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally.

Reports results on 25 November 2026

ZEAL.COZealand Pharma A/S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Reports results on 25 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.